Sobotka T J, Ekelman K B, Slikker W, Raffaele K, Hattan D G
Center for Food Safety and Applied Nutrition, Food and Drug Administration, Washington, D.C. 20204, USA.
Neurotoxicology. 1996 Fall-Winter;17(3-4):825-36.
The fact that some chemicals may adversely affect the nervous system is certainly not a new concept in regulatory toxicology. In 1982, the FDA issued testing guidelines for the safety evaluation of proposed direct food and color additives which included the assessment of nervous system toxicity as part of the general toxicological profile. However, these guidelines provide only broad and nonspecific recommendations as to how this assessment may best be carried out. The information derived from toxicity screening studies conducted according to these guidelines enable little more than the detection of clearly evident adult nervous system toxicity associated with general neuropathology and overt neurological dysfunction. Little consistent or systematically documented information is typically developed about other equally important types of neurotoxic effects including, for example, behavioral dysfunction and developmental neurotoxicity. Concerns about these more subtle types of neurotoxic effects have become a prominent public health issue and have resulted in demands for an increasing level of assurance that efforts are being made to minimize even further the risks of neurotoxicity from human exposure to chemical substances. In an effort to address these concerns, the FDA is including specific attention to neurotoxicity in a proposed revision of its toxicity testing guidelines for food additives. These proposed guidelines focus on a more careful evaluation of structural and functional measures of neurotoxicity as a routine component of safety assessment. This focus will enable the development of the type of information needed for a more effective assessment of the full spectrum of neurotoxic hazards. The revised guidelines for neurotoxicity testing will be discussed in terms of the FDA's overall approach to safety assessment.
某些化学物质可能会对神经系统产生不利影响,这在监管毒理学中当然不是一个新概念。1982年,美国食品药品监督管理局(FDA)发布了关于拟议的直接食品和色素添加剂安全性评估的测试指南,其中包括将神经系统毒性评估作为一般毒理学概况的一部分。然而,这些指南仅就如何最好地进行这种评估提供了宽泛且不具体的建议。根据这些指南进行的毒性筛查研究得出的信息,仅仅能够检测出与一般神经病理学和明显神经功能障碍相关的明显的成人神经系统毒性。对于其他同样重要的神经毒性效应类型,比如行为功能障碍和发育神经毒性,通常很少能获得一致的或系统记录的信息。对这些更为细微的神经毒性效应的担忧已成为一个突出的公共卫生问题,并导致人们要求进一步确保正在努力将人类接触化学物质产生神经毒性的风险降至更低。为了回应这些担忧,FDA在其食品添加剂毒性测试指南的拟议修订版中特别关注神经毒性。这些拟议的指南将对神经毒性的结构和功能指标进行更仔细的评估作为安全评估的常规组成部分。这一重点将有助于获取更有效评估全谱神经毒性危害所需的信息类型。将从FDA安全评估的整体方法角度讨论修订后的神经毒性测试指南。